Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a share buy-back program of up to DKK 150 million as announced on December 11, 2024. The decision to launch the program is driven by a ...

The Company announces that on 8 January 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1296 pence per share. Further details are set out below: ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA POSTS RECORD SALES OF CHF 11.76 BILLION IN 2024 -- ...

The China stock market has moved higher in back-to-back sessions, collecting almost 25 points or 0.8 percent along the way. The ...

The Singapore stock market has moved higher in five straight sessions, gathering more than 100 points or 1.5 percent along the way.

The Australian market is trading notably lower on Thursday, snapping a five-session winning session, following the mixed cues from ...

Many Federal Reserve officials believe a careful approach to interest rate decisions will be necessary over the coming quarters, ...

Time and date: 2.00 p.m. Wednesday, 29 January 2025 Place: The company’s address: Hjulmagervej 55, 9000 Aalborg, Denmark ...

Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...